drug abuse

Sen. Paul Visits Corbin

Sen. Paul visits Corbin
“Idleness leads to drug addiction, and drug addiction leads to idleness. I find rehabilitation comes from working. I saw that at the SEKRI plant today. … One big problem with drugs — I think too many… Continue reading

Cocaine Addiction Treatment and Home Remedies: Use of the Scopolamine Transdermal Patch.

Cocaine Addiction Treatment and Home Remedies: Use of the Scopolamine Transdermal Patch.

Subst Use Misuse. 2013 Aug 7;
Gambelunghe C, Bacci M, Aroni K, De Falco F, Ayroldi EM

Recently, there has been an enormous increase in the number… Continue reading

Addiction: Smoking and Craving a Drink?

Addiction: Smoking and craving a drink?

Nat Rev Neurosci. 2013 Aug 7;
Flight MH

HubMed – addiction

A Bibliometric Analysis of European versus USA Research in the Field of Addiction. Research on Alcohol, Narcotics, Prescription Drug Abuse, Tobacco and… Continue reading

Why Social Attachment and Oxytocin Protect Against Addiction and Stress: Insights From the Dynamics Between Ventral and Dorsal Corticostriatal Systems.

Why Social Attachment and Oxytocin Protect against Addiction and Stress: Insights from the Dynamics between Ventral and Dorsal Corticostriatal Systems.

Pharmacol Biochem Behav. 2013 Jul 31;
Tops M, Koole SL, Ijzerman H, Buisman-Pijlman FT

The present article advances a… Continue reading

Noonan: The Humble Pope, and the Beltway Cats

Noonan: The Humble Pope, and the Beltway Cats
I like everything Pope Francis is doing because he's trying to shake things up. The minute popes become popes they become insiders. They are inside the Vatican, inside the curia, inside the… Continue reading

[Buprenorphine Transdermal Patch (Norspan Tape)].

[Buprenorphine transdermal patch (Norspan tape)].

Masui. 2013 Jul; 62(7): 799-807
Hamaguchi S, Ikeda T

Buprenorphine is a chemically synthesized opioid characterized as the partial mu agonist and kappa antagonist, and transdermal buprenorphine patch will be considered useful as a… Continue reading

Cory Monteith's Substance Abuse Struggle Will Inspire Others Who 'Don'T Have

Cory Monteith's Substance Abuse Struggle Will Inspire Others Who 'Don't Have
Monteith had been open about his struggle with substance abuse and voluntarily entered a treatment facility in March for his issues. Following his stay in rehab, Monteith was… Continue reading

North Jersey 'Pill Mills' Cashing in on Painkiller Addiction

North Jersey 'pill mills' cashing in on painkiller addiction
They came by vanloads from downtown Newark. The Medicaid recipients and homeless drug addicts piled into a medical center in a strip mall in Passaic, where they got cursory examinations and… Continue reading

Polioencephalomalacia Secondary to Hypernatremia in Squirrel Monkeys (Saimiri Sciureus).

Polioencephalomalacia Secondary to Hypernatremia in Squirrel Monkeys (Saimiri sciureus).

Vet Pathol. 2013 Jul 30;
Macri SM, Crowell AM, Fenn MS, Knight HL, Westmoreland SV, Miller AD

Squirrel monkeys (Saimiri spp) are one of the most consistently used New World… Continue reading

A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.

A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.

J Addict Med. 2013 Jul 26;
Wei X, Wang L, Wang X, Li J, Li H, Jia W

We analyzed a 6-year methadone maintenance treatment (MMT) retention rate in 8 MMT clinics in Xi’an and the factors that influenced the retention rate.We conducted a 6-year retrospective dynamic cohort study of 5849 eligible patients from 2006 to 2011. Participants were serially enrolled on the basis of opioid addiction, age, residence status, and civil capacity. Cumulative retention in treatment was calculated using survival analyses (life tables) on the basis of the number of days in MMT. We also used the Cox proportional hazard regression model to analyze the factors that may influence treatment retention.The MMT retention varied from a less than 1 month to a maximum of 71.2 months; the average dose was 48.76 ± 17.03 mg/d. The cumulative retention for 12, 24, 36, 48, 60, and 72 months after MMT initiation were 0.87, 0.76, 0.66, 0.57, 0.49, and 0.43, respectively. The MMT retention rate was significantly associated with factors that included the particular clinic for MMT, the year when the subject initiated MMT, average daily dose, hidden drug use, sex, age, length of drug abuse history, needle sharing, living arrangements, and employment status.The 6-year retention rates for MMT in the 8 clinics in Xi’an were higher than those reported in other studies of other clinics. High therapeutic doses (>60 mg/d) could reduce the risk of… Continue reading